SYRE
Spyre Therapeutics Inc.
87.10$
-1.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 13.31 | 11.82 | 8.60 | 4.67 | 0.00 | 0.00 | 7.13 | 0.69 | 0.13 | 0.02 | 0.00 | |
| 0.03 | 0.19 | – | – | – | 0.71 | 0.76 | 0.76 | 0.58 | 0.14 | 0.02 | 2.68 | |
| -0.03 | 13.11 | 11.82 | 8.60 | 4.67 | -0.71 | -0.76 | 7.13 | 0.69 | -0.01 | 0.02 | -2.68 | |
| 12.48 | 25.05 | 46.32 | 37.70 | 44.09 | 50.55 | 27.94 | 21.70 | 17.38 | 12.98 | 3.46 | 2.68 | |
| – | 13.01 | – | – | – | 13.93 | 10.23 | 10.39 | 8.46 | 5.79 | 0.97 | 0.75 | |
| 16.24 | 38.06 | 67.75 | 54.34 | 59.25 | 62.15 | 37.41 | 32.09 | 25.84 | 35.26 | 4.43 | 0.59 | |
| -16.27 | -24.75 | -55.93 | -45.74 | -54.58 | -62.86 | -38.17 | -24.96 | -25.15 | -35.13 | -4.43 | -3.27 | |
| -18.91 | -24.71 | -55.40 | -45.01 | -53.25 | -61.23 | -37.89 | -24.97 | -24.90 | -49.12 | -4.42 | -2.42 | |
| – | – | – | – | – | – | -0.28 | 0.05 | -0.04 | 0.00 | 0.00 | 0.00 | |
| -18.91 | -24.71 | -55.40 | -45.01 | -53.25 | -61.23 | -37.89 | -25.02 | -24.86 | -49.12 | -4.42 | -2.42 | |
| -18.87 | -24.55 | -55.59 | -45.32 | -54.23 | -60.53 | -37.13 | -24.37 | -24.32 | -35.13 | -4.42 | -3.27 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.